![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 29, 2023 10:58:57 AM
$nwbo#DISRUPTOR #CANCER $NWBO #SPOOFING
— maverick_1 (@maveric92283613) September 28, 2023
Collaborators: $MRK $REGN $BMY $JNJ $GILD $AMGN $RHHBY $AZN
1st Shot of MANY across the BOW:
From Greg Zivic EMD…
“Innes figured! LGoldman after them.
Y NWBO UP 2 cover. 12 million shares (0f 49) ”
EVERY BIG RX NEEDS NWBO
GENERATIONAL $
@alphavestcap
Quote
maverick_1
@maveric92283613
·
15h
#DISRUPTOR #CANCER $NWBO #SPOOFING
Collaborators: $MRK $REGN $BMY $JNJ $GILD $AMGN $RHHBY $AZN
1st Shot of MANY across the BOW:
From Greg Zivic EMD…
“Innes figured! LGoldman after them.
Y NWBO UP 2 cover. 12 million shares (0f 49) ”
EVERY BIG RX NEEDS NWBO
GENERATIONAL $
flipper44
In that small trial, the DCVax-l + Poly-ICLC arm showed:
100% unmethylated GBM (idh wildtype) patients lived over two years. (n = 4)
100% methylated GBM (idh wildtype) patient lived over four years. (n = 1)
100% Grade III brain tumor patients are still alive. (Between six and ten years). (n = 4)
https://www.researchsquare.com/article/rs-3287211/v1
Yes, the trial did not power itself for survival, but the results in that arm are nonetheless stunning.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM